A new editorial paper was published in Oncotarget titled "Unveiling the non-canonical functions of EZH2 in prostate cancer." Prostate cancer (PCa) is ranked as the second leading cause of ...
Tallmadge, OH, April 03, 2026 (GLOBE NEWSWIRE)-- This report presents publicly available information about ProstaCleanse, including ingredient-level research context, company-provided product details, ...
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function. Researchers have found that the use of the NeuroSAFE technique to guide ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
The proapoptotic protein, prostate apoptosis response-4 (Par-4), acts as a tumor suppressor in prostate cancer cells. The serine/threonine kinase casein kinase 2 (CK2) has a well-reported role in ...
Early detection and management of prostate cancer has improved the chances of survival in many patients. Erectile dysfunction (ED) is a common side effect in men receiving prostate cancer treatment, ...
Washington, March 25, 2026 (GLOBE NEWSWIRE)-- After 45, prostate health becomes one of the most significant factors shaping a man's quality of life. Frequent bathroom trips, disrupted sleep, weakening ...
Please provide your email address to receive an email when new articles are posted on . Exercise 3 days a week conferred more benefit than usual care for men with prostate cancer and erectile ...